무바늘 기기 : 각종 기술과 세계 시장

The global market for needle-free devices was valued at $15.5 billion in 2024 and is estimated to increase from $17.0 billion in 2025 to reach $27.7 billion by 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 through 2030.

The North American market for needle-free devices was valued at $6.7 billion in 2024 and is estimated to increase from $7.4 billion in 2025 to reach $12.1 billion by 2030, at a CAGR of 10.4% from 2025 through 2030.

The Asia-Pacific market for needle-free devices was valued at $2.5 billion in 2024 and is estimated to increase from $2.8 billion in 2025 to reach $5.0 billion by 2030, at a CAGR of 12.1% from 2025 through 2030.

Report Scope

Both qualitative and quantitative data on the current market dynamics and trends are presented in this report on the global market for needle-free devices. The report also assesses recent technological developments and product performance. Analyses of the most popular products, clinical trials, new product approvals, and emerging technologies are also included. The market prospects for five regions-North America, Europe, Asia-Pacific, South America, and the Middle East and Africa (MEA)-are discussed. The report also includes profiles of leading companies and their strategies.

The global market is segmented into the following product types: needle-free injectors, inhaler technologies, transdermal patch technologies and other novel technologies. By application, the market is segmented into vaccines, pain management, insulin delivery, pediatric injections and others. By end-user, the market is segmented into hospitals and clinics, homecare settings, and research and academic institutions. For market estimates, data has been provided for 2024 as the base year, with forecasts for 2025 through 2030.

Report Includes

• 49 data tables and 56 additional tables
• An overview of the global market for needle-free devices and technologies
• Analyses of global market trends with data from 2022 to 2025 and projected CAGRs through 2030
• Highlights of the current and future market potential and quantification of the market by product type, application, end user and region
• Assessment of the recent developments, key technological updates and product performance within the needle-free devices market
• Insight into various needle-free technologies that are used in drug delivery and their application areas
• Discussion of government regulations that can affect the global needle-free devices market
• Identification of challenges and discussion on how to overcome those to reach its commercialization potential, and ESG trends of the market
• Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
• Company profiles of major players within the industry, including GSK plc., Novartis AG, Viatris Inc., and PharmaJet

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Macroeconomic Factors
• Impact of U.S. Tariffs on the Pharmaceutical and Medical Device Industries
• Population Demographics and Aging Populations
• Healthcare Infrastructure and Spending
• Regulatory and Policy Landscape
• Technological Advances and Funding
• Geopolitical Risks, Trade Wars, and Supply Chain Disruptions
• Porter's Five Forces Analysis
• Potential for New Entrants (Moderate to High)
• Bargaining Power of Suppliers (Low to Moderate)
• Bargaining Power of Buyers (Moderate to High)
• Threat of Substitute Products or Services (High)
• Industry Level of Competitiveness (Moderate to High)

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Increasing Incidence of Needlestick Injuries
• Preference for Painless Drug Delivery
• Demand for Home Healthcare and Self-Administration
• Market Restraints
• Cost of Needle-Free Technology
• Limitations of Large Volume and Intravenous Administration Systems
• Market Opportunities
• Product Innovation
• Increased Investments in Healthcare in Emerging Markets

Chapter 4 Regulatory Landscape

• Overview
• Regulatory Scenario in the U.S.
• Regulatory Scenario in Europe
• Regulatory Scenario in Japan
• Regulatory Scenario in China
• FDA-Approved Inhalers
• FDA-Approved Transdermal Patch

Chapter 5 Emerging Trends and Pipeline Analysis

• Emerging Trends
• Smart Patches
• Smart Inhalers
• Sonophoresis
• 3D-Printed Microarray Patches
• Dissolving/Degradable Patches
• Pipeline Analysis
• Takeaways
• Patent Analysis
• Inhaler Technologies
• Transdermal Patches
• Needle-Free Injectors
• Findings

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Breakdown by Product Type
• Takeaways
• Inhaler Technologies
• Transdermal Patches
• Needle-free Injectors
• Other Novel Technologies
• Market Breakdown by Application
• Takeaways
• Vaccines
• Pain Management
• Insulin Delivery
• Pediatric Drug Delivery
• Other Applications
• Market Breakdown by End-User
• Takeaways
• Hospital and Clinics
• Homecare Settings
• Research and Academic Institutions
• Geographic Breakdown
• Market Breakdown by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 7 Competitive Intelligence

• Takeaways
• Market Shares of Leading Companies
• Strategic Analysis

Chapter 8 Sustainability in Needle-Free Devices: ESG Perspective

• Overview
• Environmental Sustainability
• Social Responsibility
• Governance Perspective
• ESG Risk Ratings
• Concluding Remarks from BCC Research

Chapter 9 Appendix

• Research Methodology
• Sources
• Abbreviations
• Company Profiles
• AKRA DERMOJET
• APTARGROUP INC.
• ARX LLC.
• ASTRAZENECA
• AVAXZIPEN
• CROSSJECT
• ENDO INC.
• GSK PLC.
• HALOZYME INC.
• MIKA MEDICAL CO.
• NOVARTIS AG
• NUGEN MEDICAL DEVICES
• PHARMAJET
• PRESSPART VERWALTUNGS GMBH
• VIATRIS INC.
• Emerging Start-ups/Market Disruptors